Cumberland Pharmaceuticals stock is up more than 90% in morning trading after the FDA approved the expanded use of its pain medication. More
Articles
Shiba Inu Just Hit a Milestone, But That’s Not a Reason to Buy
Until this pupcoin sees big improvement in its functionality and utility, don't expect Shiba Inu to make big moves higher. More
Why Omicron Is Exactly What Digital World Acquisition Needed
While the world anxiously observes the new variant of the coronavirus, DWAC stock is potentially among the few beneficiaries. More
2 Reasons Why Shiba Inu Could Be a Slow and Steady Gainer
Shiba Inu could stabilize itself and be a prospect for steady gains, instead following in Dogecoin's footsteps and losing all of its gains. More
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
Good morning, investor! We're starting off Tuesday with a breakdown of the biggest pre-market stock movers you need to know about! More
All Bets Are Off Whether the Lucid Stock Rally Can Continue
While the LCID stock run-up has lasted longer than expected, investors may soon start to take their foot off the accelerator. More
Why Skillz Is a Disappointment as Bears Bet Against it
SKLZ stock has to prove itself to shareholders, who are growing impatient waiting for its acquisitions to add meaningfully to profits. More
